Olokizumab

CAS No. 1007223-17-7

Olokizumab( —— )

Catalog No. M36700 CAS No. 1007223-17-7

Olokizumab (CDP 6038) is a humanized monoclonal antibody targeting interleukin-6 (IL-6), primarily used in rheumatoid arthritis (RA) research .

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 566 In Stock
10MG 845 In Stock
25MG 1226 In Stock
50MG 1646 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Olokizumab
  • Note
    Research use only, not for human use.
  • Brief Description
    Olokizumab (CDP 6038) is a humanized monoclonal antibody targeting interleukin-6 (IL-6), primarily used in rheumatoid arthritis (RA) research .
  • Description
    Olokizumab (CDP 6038) is a humanized monoclonal antibody targeting the interleukin-6 (IL-6). Olokizumab can be used in research of rheumatoid arthritis (RA).
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1007223-17-7
  • Formula Weight
  • Molecular Formula
    ——
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    ——
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Kretsos K, et, al. Model-Based Optimal Design and Execution of the First-Inpatient Trial of the Anti-IL-6, Olokizumab. CPT Pharmacometrics Syst Pharmacol. 2014 Jun 18;3(6):e119.?
molnova catalog
related products
  • Eflucimibe

    Eflucimibe (L0081) is an acyl coenzyme A: cholesterol acyltransferase inhibitor for the treatment of cardiovascular disease and endocrine and metabolic disorders, and can be used to study atherosclerosis and hyperlipidemia.

  • Cedrusin

    Cedrusin shows a cytotoxic effect on A375 and HeLa cells.

  • Minoxidil sulphate

    Minoxidil sulphate is the active metabolite required to exert the vasodilatory and hair growing effects of minoxidil.